|
|
|
News Details
|
|
|
VHEST, the largest trial in Syria
|
VHEST Trial (Data Collection)
15/08/2008
Ibn-Alhaytham's cardiovascular medical representatives will start to collect the files/folders from physicians today. Today is the dead line of this trial and physician should have included 15 different patients.
VHEST is an Observational Study on the Efficacy, Safety and Tolerability of Valsartan and Valsartan HCT Combination in Managing Patients with Essential Hypertension in Actual Practice in Syria.
This is the first study in Syria that includes a wide range of medical physicians - one hundreds - from all the major cities in syria. VHEST study will recruite 1500 hypertensive patients according to certain inclusion and exclusion criteria.
For more information about Valsartan visit the following link:
Valsartan (Ibn-Alhaytham)
For more information VHEST Trial visit the following link:
VHEST Trial
|
|
|